Perceptions of cannabis as a stigmatized medicine: a qualitative descriptive study

Harm Reduction Journal

Jane Buxton⁵  N Rielle Capler¹  John L Oliffe⁴  Lynda G Balneaves⁴  Laura JL Bissell²  Joan L Bottorff³ 

[1] Interdisciplinary Graduate Studies Program, University of British Columbia, T201 2211 Wesbrook Mall, Vancouver, BC, V6T 2B5, Canada;Faculty of Health and Social Development, University of British Columbia’s Okanagan campus, Kelowna, BC, V1V 1V7, Canada;Institute for Healthy Living and Chronic Disease Prevention, University of British Columbia’s Okanagan campus, 3333 University Way, Kelowna, BC, V1 1V7, Canada;School of Nursing, University of British Columbia, T201 2211 Wesbrook Mall, Vancouver, BC, V6T 2B5, Canada;School of Population and Public Health, University of British Columbia, 171 - 2206 East Mall, Vancouver, V6T 1Z3, Canada

关键词: Social consequences;    Legal consequences;    Cannabis;    Stigma;    Medical marijuana;    Cannabis;   

Others  :  809929
DOI  :  10.1186/1477-7517-10-2

 received in 2012-05-23, accepted in 2013-02-11,  发布年份 2013

【 摘 要 】

Background

Despite its increasing prevalence and acceptance among the general public, cannabis use continues to be viewed as an aberrant activity in many contexts. However, little is known about how stigma associated with cannabis use affects individuals who use cannabis for therapeutic purposes (CTP) and what strategies these individuals employ to manage associated stigma. The aim of this Canadian study was to describe users’ perceptions of and responses to the stigma attached to using CTP.

Methods

Twenty-three individuals who were using CTP for a range of health problems took part in semi-structured interviews. Transcribed data were analyzed using an inductive approach and comparative strategies to explore participants’ perceptions of CTP and identify themes.

Results

Participant experiences of stigma were related to negative views of cannabis as a recreational drug, the current criminal sanctions associated with cannabis use, and using cannabis in the context of stigmatizing vulnerability (related to existing illness and disability). Strategies for managing the resulting stigma of using CTP included: keeping CTP ‘undercover’; educating those who did not approve of or understand CTP use; and using cannabis responsibly.

Conclusions

Understanding how individuals perceive and respond to stigma can inform the development of strategies aimed at reducing stigma associated with the use of CTP and thereby address barriers faced by those using this medicine.

【 授权许可】

   
2013 Bottorff et al; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Tramer MR, Carroll D, Campbell F, Reynolds DJM, Moore A, McQuay H: Cannabinoids for control of chemotherapy induced nausea and vomiting: Quantitative systematic review. BMJ 2001, 323(16):1-8.
• [2]Ware M, Rueda S, Singer J, Kilby D: Cannabis use by persons living with HIV/AIDS: Patterns and prevalence of use. J Cannabis Therapeutics 2003, 3(2):3-15.
• [3]Hathaway AD: Cannabis users' informal rules for managing stigma and risk. Deviant Behav 2004, 25(6):559-577.
• [4]Tjepkema M: Use of cannabis and other illicit drugs. Health Rep 2004, 15(4):41-47.
• [5]Stockwell T, Sturge J, Jones W, Fischer B, Carter C: Cannabis use in British Columbia: Patterns of use, perceptions, and public opinion as assessed in the 2004 Canadian Addiction Survey - Bulletin 2. Centre for Addictions Research of British Columbia (CARBC), Vancouver, Canada; 2004. http://carbc.ca/Portals/0/PropertyAgent/558/Files/19/CARBCBulletin2.pdf webcite
• [6]Savas D: Public opinion and illicit drugs: Canadian attitudes towards decriminalizing the use of marijuana. The Fraser Institute, Vancouver, Canada; 2001.
• [7]Hathaway AD, Erickson PG, Lucas P: Canadian public opinion on cannabis: How far out of step is it with the existing law? Can Rev Soc Pol 2007, 59:44-55.
• [8]Johnson BD, Ream GL, Dunlap E, Sifaneck SJ: Civic norms and etiquettes regarding marijuana use in public settings in New York City. Subst Use Misuse 2008, 43(7):895-918.
• [9]Lucas P: Moral regulation and the presumption of guilt in Health Canada's medical cannabis policy and practice. Int J Drug Policy 2009, 20(4):296-303.
• [10]Goffman E: Stigma: Notes on the management of spoiled identity. Prentice - Hall, Englewood Cliffs, NJ; 1963.
• [11]Link B, Struening E, Rahav M, Phelan J, Nuttbrock L: On stigma and its consequences: Evidence from a longitudinal study of men with dual diagnoses of mental illness and substance abuse. J Health Soc Behav 1997, 38(2):177-190.
• [12]Weiss MG, Ramakrishna J, Somma D: Health-related stigma: Rethinking concepts and interventions. Psychol Health Med 2006, 11(3):277-287.
• [13]Young M, Stuber J, Ahern J, Galea S: Interpersonal discrimination and the health of illicit drug users. Am J Drug Alcohol Abuse 2005, 31(3):371-391.
• [14]Corrigan PW: The impact of stigma on severe mental illness. Cogn Behav Pract 1998, 5(2):201-222.
• [15]Holzemer WL, Human S, Arudo J, Rosa ME, Hamilton MJ, Corless I, et al.: Exploring HIV stigma and quality of life for persons living with HIV infection. J Assoc Nurses AIDS Care 2009, 20(3):41-50.
• [16]Jacoby A, Snape D, Baker A: Epilepsy and social identity: The stigma of a chronic neurological disorder. Lancet Neurol 2005, 4(3):171-178.
• [17]Looper KJ, Kirkmayer LJ: Perceived stigma in functional somatic syndromes and comparable medical conditions. J Psychosom Res 2004, 57:373-378.
• [18]Ahern J, Stuber J, Galea S: Stigma, discrimination and the health of illicit drug users. Drug Alcohol Depend 2007, 88(2–3):188-196.
• [19]Corrigan PW, Sachiko AK, O'Shaughnessy J: The public stigma of mental illness and drug addiction: Findings from a stratified random sample. J Soc Work 2009, 9(2):139-147.
• [20]Krieger N, Sidney S: Prevalence and health implications of anti-gay discrimination: A study of black and white women and men in the CARDIA cohort. Int J Health Serv 1997, 27(1):157-176.
• [21]Landrine H, Klonoff EA, Gibbs J, Manning V, Lund M: Physical and psychiatric correlates of gender discrimination: An application of the schedule of sexist events. Psychol Women Q 1995, 19(4):473-492.
• [22]Canadian AIDS Society: Cannabis as Therapy for People Living with HIV/AIDS: ‘Our Right, Our Choice’. Canadian AIDS Society, Ottawa, Ontario; 2006.
• [23]Page SA, Verhoef MJ: Medicinal marijuana use: Experiences of people with multiple sclerosis. Can Fam Physician 2006, 52:64-72.
• [24]Curry WNL: Hyperemesis gravidarum and clinical cannabis: To eat or not to eat? J Cannabis Therapeutics 2002, 2(3/4):61-81.
• [25]Sandelowski M: Whatever happened to qualitative description? Res Nurs Health 2000, 23(4):334-340.
• [26]Lincoln YS, Guba EG: Naturalistic Inquiry. Sage, Newbury Park; 1985.
• [27]Sullivan-Bolyai S, Bova C, Harper D: Developing and refining interventions in persons with health disparities: The use of qualitative description. Nurs Outlook 2005, 53(3):127-133.
• [28]Canada H: Information for the patient- marihuana (cannabis). Health Canada, Ottawa, ON; 2006.
• [29]Canadian AIDS Society: Submission of the Canadian AIDS society on the Proposed Amendments to the Marihuana Access Regulations. Canadian AIDS Society, Ottawa, ON; 2004.
• [30]Canadian Cancer Society: Medicinal use of marijuana. Canadian Cancer Society, Toronto, ON; 2002.
• [31]Canadian Medical Association Journal: Marijuana: Federal smoke clears, a little. CMAJ 2001, 164(10):1397.
• [32]Capler R, Black H: Up in smoke: The illusion of legal medical marijuana. Living+ 2003, Nov-Dec:19–21. https://www.thecompassionclub.org/sites/default/files/documents/BCCCS_up_in_smoke.pdf webcite
• [33]Capler R, Black H: British Columbia Compassion Club Society Response to MMAR amendments. British Columbia Compassion Club Society, Vancouver, BC; 2004.
• [34]Mernagh Rv 2011. http://www.marijuanalaws.ca/pdf/Mernagh-Ruling-Apr13-2011.pdf webcite
• [35]Capler R, Lucas P: Guidelines for the Community-Based Distribution of Medical Cannabis in Canada. British Columbia Compassion Club Society and Vancouver Island Compassion Society, Vancouver, BC; 2006.
• [36]Statistics Canada: Low income cut-offs for 2008 and low income measures for 2007 - income research paper series. Statistics Canada, Ottawa, ON; 2009.
• [37]Fischer B, Ala-Leppilampi K, Single E, Robins A: Cannabis law reform in Canada: Is the "saga of promise, hesitation and retreat" coming to an end? CJCCJ 2003, 45(3):265-297.
• [38]The Canadian Medical Protective Association (CMPA): Medico-legal Handbook for Physicians in Canada. Canadian Medical Protective Association, Ottawa, ON; 2010.
• [39]Parker RV: Ontario Court of Appeal, ONCA 5762. 2000. http://www.ontariocourts.on.ca/decisions/2000/july/parker.htm webcite
• [40]Lucas PG: Regulating compassion: An overview of Canada's federal medical cannabis policy and practice. Harm Reduct J 2008, 5:5. BioMed Central Full Text
• [41]Campbell C: The medical use of marihuana and the right to equality. Research and Planning Branch of the Commission des Droits de la Personne et des Droits de la Jeunesse, Quebec, Canada; 2009.
• [42]Patriquin M: The limits on compassion. Macleans 2010. [Online]. http://www2.macleans.ca/2010/07/01/the-limits-on-compassion/ webcite [2010, 07/25]
• [43]Corrigan PW, Matthews AK: Stigma and disclosure: Implications for coming out of the closet. J Ment Health 2003, 12(3):235-248.
• [44]Sirey JA, Bruce Ml, Alexopolous GS, Perlick DA, Raue P, Friedman SJ, et al.: Perceived stigma as a predictor of treatment discontinuation in young and older outpatients with depression. Am J Psychiatry 2001, 158:479-481.
• [45]Lichtenstein B: Stigma as a barrier to sexually transmitted infection in the American deep south: Issues of race, gender and poverty. Soc Sci Med 2003, 57:2435-2445.
• [46]Hathaway AD, Comeau NC, Erickson PG: Cannabis normalization and stigma: Contemporary practices of moral regulation. Criminol Crim Justice 2011, 11(5):451-469.
• [47]Brown L, Macintyre K, Trujillo L: Interventions to reduce HIV/AIDS stigma: What have we learned? AIDS Educ Prev 2003, 15(1):49-69.
• [48]Heijnders M, Van der Meij S: The fight against stigma: An overview of stigma-reduction strategies and interventions. Psychol Health Med 2006, 11(3):353-363.
• [49]Gaebel W, Baumann AE: Interventions to reduce the stigma associated with severe mental illness: Experiences from the open doors program in Germany. Can J Psychiatry 2003, 48(10):657-662.